ENLIVEN THERAPEUTICS INC (ELVN) Stock Cash Flow
NASDAQ:ELVN - Nasdaq - US29337E1029 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -94.83M | -89.02M | -71.58M | 1.49M | -51.38M | |||
| Depreciation Amortization | 312.00K | 317.00K | 297.00K | 610.00K | 100.00K | |||
| Change In Working Capital | -2.40M | -4.54M | 1.40M | -5.36M | 510.00K | |||
| Taxes Paid | N/A | 232.00K | N/A | N/A | N/A | |||
| Other non cash items | 22.96M | 20.06M | 8.62M | -32.31M | 4.00M | |||
| OPERATING CASH FLOW | -73.96M | -73.19M | -61.27M | -35.57M | -46.77M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -44.00K | -44.00K | -149.00K | -360.00K | -10.00K | |||
| Other Investing Activity | -16.64M | -35.95M | -148.26M | 76.88M | -1.62M | |||
| INVESTING CASH FLOW | -16.68M | -36.00M | -148.41M | 76.52M | -1.63M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Stock Issued/Repurchased | 43.13M | 133.16M | 399.00K | 0.00 | 49.68M | |||
| Other Financing Activity | N/A | 0.00 | 233.89M | -1.23M | -580.00K | |||
| FINANCING CASH FLOW | 43.13M | 133.16M | 234.29M | -1.23M | 49.10M | |||
| CHANGE IN CASH | -47.51M | 23.98M | 24.61M | 39.72M | 700.00K | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -73.96M | -73.19M | -61.27M | -35.57M | -46.77M | |||
| Capital Expenditure | -44.00K | -44.00K | -149.00K | -360.00K | -10.00K | |||
| FREE CASH FLOW | -74.00M | -73.24M | -61.42M | -35.93M | -46.78M | |||
All data in USD